Albemarle (ALB) to Release Earnings on Wednesday

Albemarle (NYSE:ALB - Get Free Report) is expected to post its Q1 2025 earnings data after the market closes on Wednesday, April 30th. Analysts expect the company to announce earnings of ($0.37) per share and revenue of $1.18 billion for the quarter.

Albemarle (NYSE:ALB - Get Free Report) last announced its quarterly earnings data on Wednesday, February 12th. The specialty chemicals company reported ($1.09) earnings per share for the quarter, missing the consensus estimate of ($0.60) by ($0.49). Albemarle had a negative return on equity of 1.72% and a negative net margin of 21.93%. On average, analysts expect Albemarle to post $0 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Albemarle Price Performance

Albemarle stock opened at $54.76 on Wednesday. Albemarle has a 1 year low of $49.43 and a 1 year high of $137.50. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.19 and a current ratio of 1.95. The firm has a 50 day moving average price of $70.11 and a 200 day moving average price of $86.54. The company has a market cap of $6.44 billion, a price-to-earnings ratio of -4.89 and a beta of 1.59.

Albemarle Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, April 1st. Stockholders of record on Friday, March 14th were paid a dividend of $0.405 per share. The ex-dividend date of this dividend was Friday, March 14th. This represents a $1.62 annualized dividend and a dividend yield of 2.96%. Albemarle's dividend payout ratio is presently -14.46%.

Wall Street Analyst Weigh In

ALB has been the topic of a number of research analyst reports. Deutsche Bank Aktiengesellschaft reduced their target price on Albemarle from $109.00 to $105.00 in a report on Wednesday, February 12th. Clarkson Capital started coverage on Albemarle in a research note on Tuesday, January 14th. They issued a "buy" rating and a $112.00 price objective on the stock. Citigroup dropped their target price on shares of Albemarle from $85.00 to $64.00 and set a "neutral" rating for the company in a research report on Tuesday, April 15th. Royal Bank of Canada reduced their price target on shares of Albemarle from $133.00 to $114.00 and set an "overweight" rating on the stock in a research report on Wednesday, February 12th. Finally, Scotiabank dropped their price objective on shares of Albemarle from $85.00 to $75.00 and set a "sector perform" rating for the company in a research report on Tuesday, February 18th. Two equities research analysts have rated the stock with a sell rating, thirteen have assigned a hold rating and five have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus price target of $96.05.

Albemarle Company Profile

Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Energy Storage, Specialties and Ketjen. The Energy Storage segment offers lithium compounds, including lithium carbonate, lithium hydroxide, and lithium chloride; technical services for the handling and use of reactive lithium products; and lithium-containing by-products recycling services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.